한글목차

헬스케어 수탁 연구 아웃소싱(CRO) 시장 규모는 2025년 613억 7,000만 달러에서 2034년에는 1,154억 1,000만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 7.27%로 성장할 전망입니다.

헬스케어 위탁연구 아웃소싱(CRO) 시장은 임상연구 및 의약품 개발에서 효율적이고 비용 효율적인 솔루션에 대한 수요가 증가함에 따라 큰 폭의 성장이 예상되고 있습니다. 제약사 및 생명공학 기업이 업무 효율화와 신약 출시 기간 단축을 위해 CRO에 전문적 인사이트과 자원을 의존하는 경향이 증가하고 있습니다. 연구 역량을 강화하고자 하는 조직이 늘어나면서 임상시험 관리, 데이터 분석, 규제 대응 지원 등 다양한 서비스에 대한 수요가 급증하고 있습니다.

기술과 데이터 관리의 혁신이 헬스케어 CRO 시장 전망을 형성하고 있습니다. CRO는 고급 분석 기술, 인공지능, 머신러닝의 통합을 통해 임상시험 설계 최적화, 환자 모집 개선, 데이터 무결성 강화를 실현하고 있습니다. 또한 분산형 임상시험과 원격 모니터링 솔루션의 등장으로 연구 수행 방식이 변화하고 있으며, 데이터 수집의 유연성과 효율성이 향상되고 있습니다. 변화하는 규제 환경 속에서 CRO는 규제 당국의 엄격한 요구 사항을 충족하기 위해 컴플라이언스 및 품질 보증에 점점 더 집중하고 있습니다.

또한 헬스케어 CRO 시장은 혁신을 촉진하고 연구 성과를 향상시키기 위해 CRO, 제약사, 학술기관 간의 협력 강화로 혜택을 받을 수 있을 것입니다. 이러한 환경 변화 속에서 각 이해관계자의 강점을 살린 전략적 파트너십 구축에 초점이 맞추어지고, 의약품 개발 프로세스 전반의 효율성이 향상될 것으로 보입니다. 환자 중심적 접근과 실제 증거에 대한 강조는 임상 연구가 환자의 필요와 선호에 부합하도록 보장하고, 헬스케어 CRO 서비스의 미래를 형성하는 데 중요한 역할을 할 것입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 헬스케어 수탁 연구 아웃소싱(CRO) 시장 : 서비스별

제5장 세계의 헬스케어 수탁 연구 아웃소싱(CRO) 시장 : 치료 영역별

제6장 세계의 헬스케어 수탁 연구 아웃소싱(CRO) 시장 : 최종사용자별

제7장 세계의 헬스케어 수탁 연구 아웃소싱(CRO) 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Healthcare Contract Research Outsourcing Market size is expected to reach USD 115.41 Billion in 2034 from USD 61.37 Billion (2025) growing at a CAGR of 7.27% during 2026-2034.

The healthcare contract research outsourcing (CRO) market is poised for substantial growth, driven by the increasing demand for efficient and cost-effective solutions in clinical research and drug development. As pharmaceutical and biotechnology companies seek to streamline their operations and reduce time-to-market for new therapies, the reliance on CROs for specialized expertise and resources is becoming more prevalent. The market is witnessing a surge in demand for a wide range of services, including clinical trial management, data analysis, and regulatory support, as organizations aim to enhance their research capabilities.

Innovations in technology and data management are shaping the future of the healthcare CRO market. The integration of advanced analytics, artificial intelligence, and machine learning is enabling CROs to optimize clinical trial designs, improve patient recruitment, and enhance data integrity. Additionally, the rise of decentralized clinical trials and remote monitoring solutions is transforming the way research is conducted, allowing for greater flexibility and efficiency in data collection. As regulatory environments evolve, CROs are increasingly focusing on compliance and quality assurance to meet the stringent requirements of health authorities.

Moreover, the healthcare CRO market will benefit from increased collaboration between CROs, pharmaceutical companies, and academic institutions to foster innovation and improve research outcomes. As the landscape evolves, the focus will shift towards developing strategic partnerships that leverage the strengths of each stakeholder, enhancing the overall efficiency of the drug development process. The emphasis on patient-centric approaches and real-world evidence will also play a crucial role in shaping the future of healthcare CRO services, ensuring that clinical research aligns with the needs and preferences of patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Clinical Trial Service
• Regulatory Service
• Clinical Data Management & Biometrics
• Medical Writing
• Pharmacovigilance
• Site Management Protocol
• Others

By Therapeutic Area

• Oncology / Hematology
• CNs
• CV/Metabolic
• Respiratory
• Infectious Diseases
• Immunology
• Rare Diseases
• Medical Devices
• Others

By End-user

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Academic Institutes & Government Organizations

COMPANIES PROFILED

• Syneos Health, PAREXEL International, ICON plc, PRA Health Sciences Inc, Charles River, Laboratory Corporation of America Holdings Covance, IQVIA, Medpace, Pharmaceutical Product Development LLC

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Clinical Trial Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Regulatory Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clinical Data Management & Biometrics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Medical Writing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Pharmacovigilance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Site Management Protocol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapeutic Area
• 5.2. Oncology / Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. CNs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. CV/Metabolic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Rare Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic Institutes & Government Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service
  • 7.2.2 By Therapeutic Area
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service
  • 7.3.2 By Therapeutic Area
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service
  • 7.4.2 By Therapeutic Area
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service
  • 7.5.2 By Therapeutic Area
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service
  • 7.6.2 By Therapeutic Area
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Syneos Health
  • 9.2.2 PAREXEL International
  • 9.2.3 ICON Plc
  • 9.2.4 PRA Health Sciences Inc
  • 9.2.5 Charles River
  • 9.2.6 Laboratory Corporation Of America Holdings (Covance)
  • 9.2.7 IQVIA
  • 9.2.8 Medpace
  • 9.2.9 Pharmaceutical Product Development LLC